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Abstract
Genetically controlled resistance of Anopheles gambiae mosquitoes to Plasmodium falciparum is a common trait in the
natural population, and a cluster of natural resistance loci were mapped to the Plasmodium-Resistance Island (PRI) of the A.
gambiae genome. The APL1 family of leucine-rich repeat (LRR) proteins was highlighted by candidate gene studies in the
PRI, and is comprised of paralogs APL1A, APL1B and APL1C that share $50% amino acid identity. Here, we present a
functional analysis of the joint response of APL1 family members during mosquito infection with human and rodent
Plasmodium species. Only paralog APL1A protected A. gambiae against infection with the human malaria parasite P.
falciparum from both the field population and in vitro culture. In contrast, only paralog APL1C protected against the rodent
malaria parasites P. berghei and P. yoelii. We show that anti-P. falciparum protection is mediated by the Imd/Rel2 pathway,
while protection against P. berghei infection was shown to require Toll/Rel1 signaling. Further, only the short Rel2-S isoform
and not the long Rel2-F isoform of Rel2 confers protection against P. falciparum. Protection correlates with the
transcriptional regulation of APL1A by Rel2-S but not Rel2-F, suggesting that the Rel2-S anti-parasite phenotype results at
least in part from its transcriptional control over APL1A. These results indicate that distinct members of the APL1 gene family
display a mutually exclusive protective effect against different classes of Plasmodium parasites. It appears that a gene-for-
pathogen-class system orients the appropriate host defenses against distinct categories of similar pathogens. It is known
that insect innate immune pathways can distinguish between grossly different microbes such as Gram-positive bacteria,
Gram-negative bacteria, or fungi, but the function of the APL1 paralogs reveals that mosquito innate immunity possesses a
more fine-grained capacity to distinguish between classes of closely related eukaryotic pathogens than has been previously
recognized.
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Introduction
Malaria remains a major global health problems, with more
than 300 million estimated cases and more than one million deaths
annually [1]. Plasmodium falciparum is the most common human
malaria parasite in Africa and is responsible for the majority of
mortality due to malaria. The vector mosquito, Anopheles gambiae,i s
widespread in sub-Saharan Africa, where it constitutes the major
vector of P. falciparum. Vector control has been one of the
foundations of malaria control. However, recent problems such as
the rapid spread of drug-resistant parasites and insecticide-
resistant mosquitoes have encouraged the development of a new
generation of vector-based malaria control tools. Such new vector-
based strategies might be based on the introduction into the vector
population of genetic information encoding novel desirable traits
that reduce transmission [2], or on exploiting natural selection to
promote the expansion of pre-existing desirable traits [3,4].
The high level of P. falciparum transmission in Africa, which is
sustained in large part by A. gambiae, led to the idea that this
mosquito species is generally permissive for the development of P.
falciparum. However, analysis of the field population indicates that
genetically-controlled resistance of wild A. gambiae mosquitoes to P.
falciparum in West Africa is relatively frequent [5]. Genetic
mapping led to the identification of major-effect loci for P.
falciparum resistance that cluster within the PRI of the A. gambiae
genome [4]. This same genomic region was also identified in East
African A. gambiae as a major locus controlling P. falciparum
development [6,7]. The identification of common genetic control
over susceptibility to P. falciparum infection in geographically
distant A. gambiae populations suggests that a shared and
PLoS Pathogens | www.plospathogens.org 1 September 2009 | Volume 5 | Issue 9 | e1000576widespread resistance mechanism operates in A. gambiae through-
out sub-Saharan Africa. Such a widespread trait might be an
evolutionarily old host-defense mechanism that could have been
shaped and maintained by selective pressure from malaria or other
similar pathogens.
A candidate gene study of the ,1000 predicted protein coding
sequences in the ,15 Mb PRI locus yielded two genes that
survived all filter criteria [4]. These two genes, named APL1 and
APL2, encode LRR proteins, which is a widespread motif in innate
immune proteins among animals and plants [8]. RNAi-mediated
gene silencing in an A. gambiae laboratory strain indicated that
candidate gene APL1, but not APL2, was highly protective against
the development of the rodent malaria parasite, P. berghei [4].
Subsequent reannotation of the APL1 locus revealed the original
APL1 ‘‘gene’’ to be three paralogous members of a gene family,
which were then named APL1A, APL1B and APL1C [9]. Gene-
specific knockdown assays showed that of the three paralogs, only
APL1C was responsible for the previously observed control over P.
berghei parasite intensity and infection prevalence.
Here, we functionally analyzed the joint response of APL1
family members during mosquito infection with both human and
rodent Plasmodium species. First, using a field assay system we
discovered that the action of the APL1 family conferred mosquito
resistance against wild P. falciparum. We then transferred the same
mosquito assay strain to the laboratory where we challenged
mosquitoes with in vitro cultured P. falciparum gametocytes, and
observed equivalent APL1 protection as against the wild parasites.
This provided a field-to-lab validation trail for the biological
fidelity of the assay system, and justified use of the system for
detailed laboratory dissection of APL1-based protection. To date,
a small number of genes ascertained by laboratory studies have
been shown to protect A. gambiae against P. falciparum [10–12]. A
unique aspect of the current work is that we instead ascertained
candidate P. falciparum resistance genes by initially genetically
screening the natural population, and then extracted the trait from
field to lab for functional dissection.
We report that of the three APL1 family members, only paralog
APL1A displayed a host-protective effect against P. falciparum,
which we show is mediated by a specific sub-circuit of the Rel2
signalling pathway. In contrast, we extend the observation that
only APL1C was responsible for control of P. berghei infection,
which is mediated by the Rel1 pathway, with another rodent
malaria species, P. yoelii. Thus, distinct members of the APL1
family of LRR proteins display a mutually exclusive protective
effect against different classes of Plasmodium parasites, in the
context of distinct immune signalling pathways.
Results
APL1 controls the development of natural P. falciparum
isolates in A. gambiae
We tested the role of the APL1 gene family in mosquito
susceptibility to P. falciparum using wild parasites and a colonized
strain of A. gambiae. A common APL1 family domain is highly
enough conserved at the nucleic acid level that a double-stranded
RNA, dswAPL1, efficiently silences all three paralogs. We used
dswAPL1 to analyze the summed role of the APL1 family on the
development of wild P. falciparum in the recently colonized Ngousso
strain of A. gambiae. Mosquitoes injected with dswAPL1 were
challenged by feeding on the blood of naturally-infected P.
falciparum gametocyte carriers in Cameroon. The effect of APL1
silencing on P. falciparum development was measured by deter-
mining oocyst number 7–8 d post-bloodmeal. Silencing of the
entire APL1 family resulted in a significant increase of infection
prevalence (Figure 1; p=0.006).
All gene silencing experiments presented herein were done as at
least three biological replicates of at least 30 dissected mosquitoes
per replicate (see Methods). Replicates were first analyzed
independently to determine if there were significant differences
between replicates within treatments: if not, data were pooled and
analyzed statistically; if so, pooling is not statistically valid and
replicates were instead analyzed independently and resulting p
values were combined by meta-analysis (see Methods). The
threshold of significance was defined conservatively as p=0.01.
Statistical details are summarized in Supplementary Tables S2 and
S3. Infection prevalence is the fraction of mosquitoes carrying at
least one oocyst, while parasite intensity is the number of oocysts
per mosquito determined only in the subset of mosquitoes with $1
oocyst (see Methods). The APL1 knockdown phenotype controlled
only infection prevalence, with no detectable effect on oocyst
intensity (p-value for intensity=0.926). This result indicates that
wild-type expression of the APL1 gene family has a host-protective
effect against natural genotypes of P. falciparum circulating in the
field population.
Paralog APL1A controls a developmental blockade of P.
falciparum
Having found by knockdown of the entire gene family that
APL1 is protective against P. falciparum, we wished to determine the
relative phenotypic contribution of the APL1 paralogs. For this, we
moved the experimental system to the laboratory to take
advantage of the ease and reproducibility of P. falciparum in vitro
gametocyte culture for infection of the same Ngousso mosquito
strain used in Cameroon.
There is sufficient nucleotide sequence divergence outside the
APL1 common domain to permit paralog-specific gene silencing
[9]. Targeting non-conserved regions, we produced specific
dsRNAs that diminish the expression of one paralog without
affecting the expression of the other two (Figure 2A). Of the three
genes, only the APL1A knockdown displayed a phenotype after P.
falciparum challenge, with significantly higher prevalence of P.
falciparum infection as compared to controls (Figure 2B; p=0.001).
Similar to the result described above for dswAPL1 and wild P.
Author Summary
The African malaria vector mosquito Anopheles gambiae
possesses immune mechanisms that can protect it against
infection with malaria parasites, which kill more than one
million people per year. Much work studying mosquito
response to malaria has used model rodent malaria
parasites that do not infect people, but are in the same
genus and overall share most major features with the
human parasites. Here, we show that the immune
response used by A. gambiae to protect itself against
infection by human and rodent malaria parasites utilizes
different immune signaling pathways. A family of proteins
called APL1 appears to be responsible for the ability of the
mosquito to distinguish between the human or rodent
malaria parasites. An individual APL1 relative is required for
protection against the human malaria parasite but has no
effect against the rodent parasite, and another APL1
relative is required for protection against rodent but not
human malaria. This represents the finest ability yet
demonstrated of mosquito immunity to distinguish
between relatively similar pathogens, and highlights the
distinct nature of mosquito response against human as
compared to rodent malaria parasites.
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lence, not parasite intensity. Knockdowns of APL1B or APL1C
produced phenotypes indistinguishable from the dsGFP-injected
controls, indicating that the functions of these two paralogs have
no effect on either P. falciparum prevalence of infection or parasite
intensity.
The above results suggest that the paralog APL1A is solely
responsible for the host protective effect observed in the dswAPL1
comprehensive knockdown of the APL1 gene family. Because the
two dsRNAs were tested in different experimental contexts
(dswAPL1 against wild parasites in Cameroon, dsAPL1A against
gametocyte culture in the lab), we directly compared them by
dsRNA treatment followed by challenge with cultured gameto-
cytes in the same experimental infections. We verified that
dswAPL1 silences all three APL1 paralogs, and that expression of
APL1A was diminished with equivalent efficiency by treatment
with either dswAPL1 or dsAPL1A (Figure 3A). After infection, both
dswAPL1 and dsAPL1A produced equivalent, significantly higher P.
falciparum infection prevalence than the dsGFP controls (Figure 3B;
dsAPL1A, p=0.0004; dswAPL1, p=0.0007). This result confirms
that of the APL1 family, only APL1A acts as a host protective factor
to limit infection with P. falciparum derived either from the field
population or from in vitro gametocyte culture.
Interestingly, APL1A protection appears to operate with
comparable efficiency against a multiplicity of parasite genotypes.
The replicates of the dswAPL1 treatment were each infected with
blood from a different naturally-infected gametocyte carrier in
Cameroon, who harbored different parasite genotypes (data not
shown), and yet the combined replicates of the dswAPL1 treatment
displayed significantly elevated infection prevalence. Individually,
each of the replicates also displayed the same trend of increased
prevalence, although not significantly so, probably due to the
reduced sample size. In addition, the dsAPL1A-treated mosquitoes
were challenged with cultured gametocytes of the NF54 strain,
which also contains multiple genotypes [13,14]. Thus, the APL1A-
mediated mechanism appears to protect mosquitoes against P.
falciparum in a way that is probably general and not highly sensitive
to parasite strain and genotype variation.
APL1C protects against P. berghei and P. yoelii infection
We previously demonstrated that APL1 family protection
against the rodent malaria parasite P. berghei was mediated only
by paralog APL1C in the G3 strain of A. gambiae [9]. In order to
eliminate the formal possibility that the result obtained in G3 was
a mosquito strain effect, we tested protection by the APL1 paralogs
against P. berghei in the Ngousso mosquito strain. In contrast to the
results obtained above for P. falciparum, and identically to the
results obtained in the G3 strain for P. berghei, the APL1C paralog
also strongly limits infection with P. berghei in Ngousso mosquitoes
(Figure 4; infection prevalence, p=2.825610
27; oocyst intensity,
p=0.0004). In addition, we obtained an equivalent result showing
APL1C protection against P. berghei in a third strain of A. gambiae,
the Yaounde ´ strain (data not shown). Thus, APL1C-based
protection against P. berghei appears to be a general phenomenon,
and is not restricted to a particular mosquito strain-parasite
genetic combination as would be expected if APL1C protection
displayed a large genotype-by-genotype effect.
We examined APL1 protection in Ngousso mosquitoes against
another species of rodent malaria parasite, P. yoelii, which typically
infects A. gambiae with a mixture of normal and melanized oocysts
[15]. The dsGFP-treated controls permitted a median of 1 normal
P. yoelii oocyst with 46% infection prevalence for normal oocysts
and 48% harboring melanized parasites, while dsAPL1C-treated
mosquitoes permitted a median of 28 normal oocysts with 86%
infection prevalence for normal oocysts and 1.5% harboring
melanized parasites, (dsAPL1C infection prevalence for normal
oocysts, p=6.2610
212; intensity of normal oocysts, p=1.7610
28;
presence of melanized parasites, p=6.8610
27). The APL1A or
APL1B knockdowns were not significantly different from dsGFP
controls for normal oocyst infection prevalence or intensity. Thus,
APL1C is required for control of infection prevalence and oocyst
intensity against P. yoelii similar to P. berghei, but with the difference
that at least part of the APL1C-dependent protection against P.
yoelii is mediated by the melanization response, which in this case is
also APL1C-dependent. Overall, these results indicate that among
the APL1 paralogs, APL1A is exclusively responsible for establish-
ing the permissive or non-permissive state for P. falciparum
Figure 1. APL1 protects A. gambiae against wild P. falciparum.A )
Expression of the APL1 gene family detected by RT-PCR using primers
that amplify a conserved region shared by all three APL1 genes.
Mosquitoes were injected with a dsRNA directed against the shared
region to simultaneously silence the three APL1 paralogs (dswAPL1), or
with an irrelevant control dsRNA (dsLacz). In this and subsequent
figures, the injected dsRNA is indicated above the gel columns and the
transcript detected by RT-PCR is indicated to the right of the relevant
gel row. Decreased signal in row wAPL1 indicates that dswAPL1
efficiently silences the entire APL1 family as compared to dsLacZ-
injected controls. Detection of mRNA for ribosomal protein S7 (rpS7)
was used as an internal reference. B) Silencing of the APL1 gene family
permits significantly higher infection prevalence in mosquitoes fed on
wild P. falciparum gametocytes from the natural population in
Cameroon. There was no detectable effect of dswAPL1 on parasite
intensity. Infection prevalence effects are depicted by pie charts rather
than histograms of parasite number because the significant difference
is between infected or uninfected states, not parasite intensity (n,
number of dissected mosquitoes; statistical descriptions of infections
are presented in Supplementary Tables S2 and S3).
doi:10.1371/journal.ppat.1000576.g001
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while APL1C among the paralogs limits infection by P. berghei and
P. yoelii, but has no detectable influence upon P. falciparum
development.
Rel2 controls P. falciparum infection prevalence
In Drosophila, the Toll and Imd immune pathways are
responsible for protection against a broad range of pathogens,
including fungi, Gram-positive and Gram-negative bacteria [16].
When these pathways are activated, immune signals traverse
multiple intracellular intermediates and are ultimately converted
into regulated gene expression by the action of transcription
factors Dif and Relish, respectively. Orthologs and homologs of
some of these Drosophila factors have been identified in A. gambiae
[17,18]. At the terminus of the A. gambiae Toll pathway, Rel1 (also
known as Gambif1) serves as the functional analogue of Drosophila
Dif (no direct Dif ortholog has been identified in A. gambiae), while
Rel2 is orthologous to the Drosophila transcription factor Relish
[19–21].
Protection of A. gambiae against infection by P. berghei is largely
mediated by Rel1 [9,20], which translocates to the nucleus and
activates transcription after the degradation of its cytoplasmic
inhibitor, Cactus [22]. We previously showed that APL1C
expression is required for Rel1-mediated protection against P.
berghei [9]. Here, we first asked whether Rel1 or Rel2-mediated
immune signalling controls the development of P. falciparum in A.
gambiae. We silenced the ultimate transcription factor of each
pathway in the Ngousso mosquito strain, followed by challenge
with cultured P. falciparum gametocytes. Only knockdown of Rel2,
and not Rel1, produced a phenotype, leading to a significant
increase in infection prevalence compared to dsGFP-injected
controls (Figure 5A&B, Rel2 p=0.0002, Rel1 p=0.908). Next,
we constitutively activated Rel1 by silencing the gene for its
inhibitor Cactus, followed by P. falciparum infection. The dsCactus-
treated mosquitoes, with constitutively activated Rel1, displayed
no P. falciparum infection difference as compared to controls
(Supplementary Figure S1). Together, these results indicate that
the Rel2 pathway, and not Rel1, is responsible for anti-P. falciparum
protection, which is the inverse of the immune signalling profile
that protects mosquitoes against P. berghei infection [9,20].
The Rel2-Short isoform controls APL1A gene expression
and P. falciparum infection
The infection prevalence switch from non-permissive to
permissive state for P. falciparum in the Rel2 knockdown
mosquitoes might result from the removal of an unknown intrinsic
molecular barrier to P. falciparum development that is frequent in
wild-type A. gambiae. Because the knockdowns of Rel2 and APL1A
Figure 2. Paralog APL1A limits P. falciparum development in A. gambiae.A )Injection of dsRNAs that individually target APL1A, APL1B,o r
APL1C specifically diminish transcript levels from the cognate genes. B) Silencing of APL1A but not APL1B or APL1C permits significantly higher
infection prevalence in mosquitoes fed on in vitro cultured P. falciparum gametocytes, with no detectable effect on parasite intensity.
doi:10.1371/journal.ppat.1000576.g002
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prevalence, we hypothesized that APL1A might be a mediator
of the P. falciparum developmental blockade imposed by Rel2.
Comparison of APL1A and Rel2 effects shows that mosquitoes
silenced for each gene displayed comparable P. falciparum infection
prevalences of 78% (Figure 2B) and 81% (Figure 5B) respectively,
where the controls in both experiments were also comparable
(57% and 59% prevalence, respectively). Thus, by magnitude of
effect, the function of APL1A appears sufficient in itself to explain
the protection by Rel2 against P. falciparum, suggesting that APL1A
could be an important mediator of Rel2 protection against this
parasite species.
To further explore the relationship between APL1A and Rel2 in
immune signalling, we first examined transcriptional regulation of
APL1A. There are two isoforms of Rel2 in A. gambiae:aFull-length
form (Rel2-F) and a Short form (Rel2-S) lacking the inhibitory
ankyrin repeats and death domain present in the full-length
protein [21]. The dsRel2 construct used above, which caused
increased P. falciparum infection prevalence in treated mosquitoes
(Figure 5B), targets a common region shared by both Rel2
isoforms. Gene silencing using the shared Rel2 construct also
abolished transcript of APL1A, but not APL1B or APL1C
(Figure 5C), indicating that transcript levels of paralog APL1A
are under Rel2 control. To distinguish effects of the Rel2 isoforms
we then used dsRel2(Ank), a knockdown construct that targets the
ankyrin domain present only in the full-length Rel2-F transcript,
which consequently silences only Rel2-F but not the shorter Rel2-S
[21]. Because Rel2-F includes the sequences present in Rel2-S,i ti s
not possible to design a Rel2-S specific knockdown. In contrast to
the absence of APL1A mRNA after treatment with dsRel2,
mosquitoes treated with dsRel2(Ank) displayed similar APL1A
transcript levels as dsGFP controls (Figure 5C). Corresponding to
the ability to control APL1A expression, dsRel2 treated mosquitoes
displayed significantly increased P. falciparum infection prevalence
while dsRel2(Ank) treated mosquitoes were not different from
controls (Figure 5D). These results indicate that the Rel2-S and
not Rel2-F isoform controls P. falciparum development in A. gambiae,
and that the ability of a Rel2 isoform to control infection or not is
correlated with its ability to regulate APL1A mRNA levels. There
was no detectable effect of dsAPL1A, dsAPL1B,o rdsAPL1C on Rel2
transcript levels (data not shown), suggesting that APL1A is
downstream of Rel2-S in an immune regulatory network that has
unidirectional polarity. Taken together, these results suggest that
some or most of the anti-P. falciparum activity of Rel2, and
specifically of the Rel2-S isoform, is dependent upon APL1A
function, and that the mechanism of anti-parasite protection
probably operates by Rel2-S transcriptional control over APL1A
expression.
Discussion
Here we show that paralogs of a mosquito LRR gene family,
APL1, display distinct activities against different species of the
genus Plasmodium. Each APL1 paralog is required for the full
protection of mosquitoes against only one of the two malaria
parasite lineages tested, and each APL1 paralog protects by
involvement in only one of two separate immune signalling
pathways. Thus, paralog APL1A is required for protection against
Figure 3. The effect of paralog APL1A alone is sufficient to explain APL1 family protective function against P. falciparum.A )RT-PCR of
individual APL1 paralogs confirms that dswAPL1 efficiently silences all three APL1 family members. Right panel verifies directly that APL1A is silenced
with equivalent efficiency by either dsAPL1A or dswAPL1. B) Treatment of mosquitoes with either dswAPL1 or dsAPL1A causes equivalent reduction in
host protection against P. falciparum infection.
doi:10.1371/journal.ppat.1000576.g003
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Imd/Rel2 pathway, while APL1C is required for protection
against P. berghei and P. yoelii but not P. falciparum, and functions in
the Toll/Rel1 pathway. These observations indicate that at least
two reciprocal and mutually exclusive host-defense mechanisms,
defined by the requirement for distinct APL1 paralogs, protect
mosquitoes from infection by different lineages of Plasmodium
parasites.
It is recognized that invertebrate innate immunity distinguishes
between broad groups of pathogens based on wide taxonomic and
molecular differences, for example Gram-positive versus Gram-
negative bacteria [16]. However, the current results demonstrate a
previously unrecognized fine level of pathogen discrimination in the
innate immune response of mosquitoes. We show that pathogens in
the same genus, displaying high morphological and genetic
relatedness, and with nearly identical mechanisms of cell invasion
and development in the mosquito host, are nevertheless recognized
and/orprocessedbymechanismsthatrequirethefunctionofclosely
relatedbut distinct members of the APL1family. The APL1 paralogs
that are required for Rel1 or Rel2-dependent host protection,
respectively, likely result from gene duplication and divergence [9].
The current study shows mutually exclusive protective function for
two of the three known APL1 paralogs, against three different
pathogens in two evolutionary groups.
Overall, these data indicate that APL1A is required for full host
protection against P. falciparum. This protection is dependent on
Rel2-S but is independent of Rel2-F (Figure 6). Further work will
be necessary to determine the structure of genetic and protein
signaling in the Rel2-F subcircuit that regulates APL1-dependent
host-protection, the mechanism of that protection, and the
patterns of natural selection that shaped the APL1 family. Recent
work reported the requirement of APL1C for stability of a protein
complex that includes the complement-related protein TEP1 and
the LRR protein LRIM1 [23,24]. The protein complex was tested
only for protection against P. berghei and not P. falciparum, but in
any case an APL1C-dependent complex could only be relevant for
protection against the rodent parasite, because as shown here
APL1C does not participate in protection against P. falciparum, and
also because the other APL1C complex member, LRIM1, was
previously shown to lack effect against P. falciparum [25]. Thus
there is currently no reason to assume that APL1A-mediated
protection against P. falciparum would be mechanistically similar to
APL1C function in a soluble protein complex, particularly given
their respective action in distinct immune signaling axes. We
further found by functional analysis that APL2 (also known as
LRRD7 [11]), another LRR-encoding candidate gene located
within the PRI locus for which we found no protective effect
against P. berghei [4], also had no significant effect upon P.
falciparum development (data not shown).
These results do not imply that the functions of APL1A and
APL1C are to protect exclusively against P. falciparum and the
rodent malaria lineage, respectively, in a ‘‘gene-for-pathogen’’
Figure 4. Paralog APL1C limits development of rodent malaria species in A. gambiae.A )Silencing of APL1C but not APL1A or APL1B permits
significantly higher oocyst intensity in mosquitoes fed on mice infected with P. berghei. B) Silencing of APL1C also permits significantly higher P.
berghei infection prevalence. Increases in both parasite intensity and infection prevalence were observed for another rodent malaria parasite, P. yoelii,
following silencing of APL1C but not APL1A or APL1B (see Results).
doi:10.1371/journal.ppat.1000576.g004
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paralogs illuminates different host-defense programs that act
against repertoires of pathogens based on some shared character-
istics, in other words, a ‘‘gene-for-pathogen-class’’ system. On this
idea, APL1A protects not only against P. falciparum but also against
as yet unknown ‘‘A-like’’ pathogens, and similarly for APL1C and
‘‘C-like’’ pathogens. We demonstrate here that activity of the
correct APL1 factor is required to orient host defense towards
human or rodent malaria parasites, respectively. There could be
other gene families with similar fine-grained function against other
pathogen classes, together yielding a potentially large combinato-
rial spectrum of protection profiles.
It is worth noting that APL1C protection against P. berghei and
P. yoelii can not be the product of shared evolutionary history
between the mosquito host and pathogen, because A. gambiae is not
a natural vector of these parasites [26]. Thus, for A. gambiae, every
experimental laboratory infection with rodent malaria represents
exposure to a novel pathogen, and consequently the pathogen-
resistance mechanisms in A. gambiae that are capable of protecting
against rodent malaria species must have been shaped and
maintained by interactions with other pathogens, and not by
rodent malaria. Consequently, it would be interesting to know
which natural pathogens of Anopheles are in the ‘‘C-like’’ group. In
addition, does an APL1C ortholog protect the natural vector of P.
berghei, A. dureni [26], against infection, and does it also function by
a Rel1-dependent mechanism? In contrast, A. gambiae does have a
shared evolutionary history with P. falciparum, and thus in principle
host resistance mechanisms, including APL1A, could have been
selected by that pathogen, although to date this has not been
proven.
Further work will be required to distinguish between a variety of
potential explanations for the reciprocal and mutually exclusive
nature of APL1 paralog protection displayed against different
pathogens. For example, APL1 proteins could be soluble factors
that recognize parasite surface molecular patterns. Their high level
of structural polymorphism [9] could be consistent with tracking
pathogen variation, but at least APL1C does not appear to
detectably bind to the P. berghei surface [24] (and data not shown).
Alternatively, APL1 proteins could be components of immune
signaling nodes, where their activity against a given pathogen class
might reflect transduction of upstream class-specific immune
signals, or differential sensitivity to attack by pathogen-derived
Figure 5. The major A. gambiae defense against P. falciparum is controlled by the short isoform of the immune signalling factor Rel2,
which regulates APL1A expression. A) Gene silencing of immune signalling factors Rel1 and Rel2 is specific for the targeted genes. B) Silencing of
Rel2 but not Rel1 permits significantly higher P. falciparum infection prevalence in treated mosquitoes. C) Genetic interactions between Rel2 isoforms
and APL1 paralogs. dsRel2 targets a common region shared by Rel2-Short and the ankyrin-domain containing Rel2-Full transcript isoforms. dsRel2
treatment diminishes both of the Rel2 transcripts, and also specifically silences APL1A but not APL1B or APL1C (RT-PCR in the horizontal row labelled
Rel2 detects both Rel2 transcripts, while the row labelled Rel2(Ank) detects only the longer Rel2-Full form). In contrast, treatment with dsRel2(Ank)
efficiently diminishes the cognate long-form transcript (RT-PCR in row labelled Rel2(Ank)) and presumably the long-form proportion of the total Rel2
transcripts detected by Rel2 RT-PCR (row Rel2), but does not affect transcript levels of APL1A, APL1B,o rAPL1C. D) Of the Rel2 isoforms, only the short-
form Rel2-S is required both for APL1A expression and for protection against P. falciparum infection. dsRel2 treatment causes significantly higher
infection prevalence, with no detectable effect on oocyst intensity. dsRel2(Ank) targets only the long-form transcript, and does not affect APL1A levels
nor influence parasite infection.
doi:10.1371/journal.ppat.1000576.g005
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polymorphism might be driven by the need to escape inactivation
by virulence factors, as hypothesized for the Relish cleavage
complex in Drosophila [27,28]. Further dissecting the theme of
potential APL1 involvement in signaling rather than direct
pathogen detection, APL1 gene products might function as guard
proteins, in the terminology of plant host-defense studies [29],
where the guard protein initiates an immune alarm if its binding
partner is subjected to virulence factor attack. In this case, the
factors guarded by APL1 proteins against virulence factor attack
might be Rel1 and/or Rel2, which could be consistent with the
requirement of APL1 activity for respective Rel function. Finally,
it is possible that APL1 proteins might serve only as sensors of
pathogen virulence factors, akin to the still-hypothetical plant
Decoy Model [30]. On this model, the APL1 proteins would be
under the functional constraints to i) serve as a molecular mimic of
the actual virulence factor target in order to provoke a virulence
factor attack, and ii) interact with a downstream host immune-
signaling factor in order to transduce an immune signal in the
event that the virulence factor is detected. In this case, the system
of APL1 paralogs and their structural variants might be explained
as the product of balancing selection to remain attractive for attack
by an evolving virulence factor.
There is not yet a large enough dataset of pathogen-host
interactions in mosquito, especially with natural pathogens like P.
falciparum, to be able to distinguish between these or other possible
models of APL1 protection. Indeed, to our knowledge this report
represents the first time that even three pathogens have been used
in a detailed functional study of mosquito host-defense. One
current need is for repeated observations using distinct pathogens
and different host genetic backgrounds. The phenotypic complex-
ity of such studies requires better measures of phenotypic
difference. The standard approach has been pooling of results
from three replicate gene knockdown experiments to statistically
test the effect of a given dsRNA, but simple pooling is not
statistically valid if there are significant differences between
replicates of the same treatment. Instead, here we first perform
statistical comparison of replicates to determine whether pooling is
appropriate, and if it is not (which can occur for many reasons), we
use meta-analysis to compare treatment effects. Such an approach,
combined with the use of a stringent significance cut-off (here we
use p=0.01), should increase comparability between experiments
and between results from different laboratories.
The APL1 genes were discovered as candidate factors within the
PRI genetic locus that displays strong control over P. falciparum
infection in nature [4]. In the current work we establish a
validation trail that proceeds from that incriminated trait locus to
the laboratory. We first functionally assayed APL1 candidate gene
protection in Cameroon against wild P. falciparum, then verified the
protective phenotype using the same mosquito strain and dsRNA
but with laboratory-cultured P. falciparum gametocytes. We were
then able to functionally dissect some of the genes and signalling
pathways underlying the original Cameroon result but under
controlled laboratory conditions. We emphasize that the work
presented herein does not prove that APL1 underlies the
phenotypic variation controlled by the PRI locus as detected in
nature. For gene incrimination, it would be necessary at least to
demonstrate a genetic association signal from the wild population.
Thus, APL1A remains only a candidate gene, although strength-
ened as an interesting genetic candidate because of its functional
properties as reported here. In contrast, based on their lack of
functional effect, paralogs APL1B and APL1C, as well as the
unrelated LRR protein APL2, can probably be excluded as
genetic candidates for natural control of P. falciparum infection.
One interesting observation is that APL1A and Rel2-S
knockdown phenotypes control P. falciparum infection prevalence
at the usual infection levels that were obtained using either natural
or in vitro parasites. This may be consistent with the previous
speculation based on the genetic behaviour of the PRI locus in the
wild population that mosquito resistance to P. falciparum could be
the wild-type state, and that susceptibility might result from major
loss-of-function mutations for an aspect of immune protection [4].
The binary infection prevalence switch observed here might have
the features of such a gain- or loss-of-function system. It is also
worth noting that, in terms of malaria transmission control, a
mechanism that reduces infection prevalence should have more
impact than reducing parasite numbers, because even one
surviving oocyst is adequate for transmission.
Figure 6. Model of APL1 paralog protection against pathogen
classes in A. gambiae. In the cartoon, the rodent malaria parasites P.
berghei and P. yoelii, which are experimental but not natural pathogens
of A. gambiae, exemplify a class of pathogens whose development in
the host is inhibited by an APL1C-dependent mechanism. The ‘‘C-like’’
class of pathogens against which APL1C protects should include other
unknown natural A. gambiae pathogens. The APL1C pathway is
depicted superimposed on the Toll pathway because the Cactus/Rel1
module regulates levels of APL1C transcript and protein [9], but the
presumptive extracellular signals that elicit APL1C protection are
unknown, as are the immune receptors and the signalling intermediates
except Cactus/Rel1. P. falciparum protection is mediated also by
unknown immune receptors and signalling intermediates, and is shown
superimposed on the Imd pathway because part of the Rel2 signaling
module is involved. Specifically, the short Rel2 isoform, Rel2-S, which
contains the Rel-homology domain (RHD) is required for host
protection against P. falciparum infection and for APL1A gene
expression. In contrast, the long Rel2 isoform, Rel2-F, does not influence
protection against P. falciparum or APL1A transcript levels, and thus is
depicted as a functionally unrelated shunt from the APL1A-terminated
pathway.
doi:10.1371/journal.ppat.1000576.g006
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Ethics statement
The use of human subjects was approved by the National
Ethical Committee of Cameroon (protocol #039/CNE/MP/06).
A signed individual written informed consent agreement was
obtained from each subject or in the case of children from their
parent or legally authorized representative before enrolment in the
study.
Mosquitoes
Mosquitoes were reared according to standard procedures [9].
The Ngousso strain was originally initiated with mosquitoes
collected in Yaounde ´, Cameroon in January 2006, and belongs to
the M molecular and Forest chromosomal forms. The strain was
reared in insectaries of OCEAC, Cameroon, or the CEPIA
mosquito production facility, Institut Pasteur, France.
Double-stranded RNA synthesis and injection
Double-stranded RNAs were synthesized from PCR amplicons
using the T7 Megascript Kit (Ambion) as described previously [9].
The sequences of primers used for synthesis of dsRNA templates
are in Supplementary Table S1. For each targeted gene, 200 ng of
dsRNA (up to 207 nl volume, depending on the concentration)
was injected into the thorax of cold-anesthetized 1–2 d-old A.
gambiae females using a nano-injector (Nanoject II, Drummond
Scientific). dsGFP or dsLacZ were used as controls. Injections were
performed with a glass capillary needle as previously described
[9,31]. Mosquitoes were challenged with malaria parasites by
feeding on the appropriate bloodmeal 4 d after dsRNA injection.
Gene knockdown verification
The efficiency of the gene knockdown effect was monitored 4 d
after dsRNA injection. cDNA synthesis was performed by using
the M-MLV reverse transcriptase and random hexamers (Invitro-
gen). In each case, 500 ng of total RNA was used in triplicate
assays. The triplicates were pooled and the mixture was used as
template for PCR analysis. The sequences of primers used for gene
knockdown verification are in Supplementary Table S1.
Experimental infection of mosquitoes with wild P.
falciparum
Gametocyte carriers were identified upon reading of thick blood
smears from 5 to 11 year old children from the Mfou district,
30 km from Yaounde ´, Cameroon. Carriers harboring over 20
gametocytes/ml were enrolled upon signature of an informed
consent form by their legal guardian. Blood was collected by
venipuncture in heparinized Vacutainer tubes, centrifuged at
2000 g for 5 minutes at 37uC, and the supernatant containing
patient serum was replaced by non-immune AB serum. A blood
volume of 350 ml was dispensed in glass feeders maintained at
37uC, and 5–6 d old female Ngousso strain mosquitoes were
allowed to feed through a Parafilm membrane for 20 min. Only
fully fed mosquitoes were retained for further analysis. Mosquitoes
were maintained in an insectary at 27uC, 85% relative humidity
on an 8% sucrose diet. The use of human subjects was approved
by the National Ethical Committee of Cameroon.
P. falciparum gametocyte culture and mosquito infection
P. falciparum isolate NF54 [32,33] was cultured using the
automated tipper-table system of Ponnudurai et al [34] as
implemented in the CEPIA mosquito infection facility of Institut
Pasteur. Briefly, a subculture of thawed NF54 stabilate was grown
in 10 ml RPMI 1640 medium supplemented with 25 mM HEPES
and L-glutamine, 10% heat-inactivated human serum, and sodium
bicarbonate at 0.2% final concentration under a constant gas
regime (5% CO2, 1% O2, 94% N2). Fresh anonymous
erythrocytes obtained from blood banks were added to 7% final
concentration. Fourteen days after initiating the subculture,
gametocyte maturity was tested by exflagellation of microgametes,
and parasitemia and numbers of mature male and female
gametocytes were counted on Giemsa stained slides.
Ten ml of culture was centrifuged at 2000 rpm, and the cell
pellet was resuspended in an equal volume of normal type AB
human serum. The infected erythrocytes were added to fresh
erythrocytes in AB human serum and were transferred to a
membrane feeder warmed to 37uC. Mosquitoes were allowed to
feed for 15 minutes, and only fully engorged females were used for
further analysis. Bloodfed mosquitoes were maintained on 10%
sucrose solution supplemented with 0.05% para-amino benzoic
acid.
Rodent malaria infection
Mosquitoes were fed on mice infected with P. berghei strain
PbGFPCON [35], which constitutively expresses green fluorescent
protein (GFP), or with P. yoelii yoelii strain 17XNL at 8–12%
parasitemia with mature gametocytes. Mosquitoes were main-
tained at 21uC( P. berghei)o r2 4 uC( P. yoelii) and 70% relative
humidity on 10% sucrose supplemented with 0.05% para-amino
benzoic acid.
Analysis of phenotypes
Midguts were dissected at 7–8 d post-infection, and for P.
falciparum or P. yoelii: stained in 0.4% mercurochrome and the
number of oocysts counted by light microscopy; or for P. berghei:n o
mercurochrome and counting by fluorescence microscopy. A
mosquito was considered infected if it harbored at least one oocyst.
Prevalence of infection is defined as the proportion of infected
mosquitoes among the total dissected mosquitoes. Infection
intensity is defined as the number of oocysts per mosquito,
determined using mosquitoes harboring at least one oocyst. It is
necessary to exclude the uninfected fraction of mosquitoes from
analysis of intensity, because otherwise the result confounds
infection prevalence and parasite intensity effects.
For each gene-silencing experiment at least 30 surviving
mosquitoes were counted for oocyst load, and at least three
independent replicate experiments were performed per experi-
mental treatment. For statistical analysis, first all experiments were
tested for statistical differences within treatments across replicates.
If no differences between replicates were detected, replicates were
pooled and differences in prevalence were tested using Chi Square
and differences in intensity were tested using non-parametric
Wilcoxon Mann-Whitney or Kruskal Wallis ANOVA on Ranks. If
differences between replicates were detected, which can occur due
to the inherent variability of Plasmodium experimental infections,
replicates were analyzed independently using the tests described
above and p values from independent tests of significance were
combined using the meta-analytical approach of Fisher [36], and
this combined p value is reported here. By either approach, the
threshold for significance was defined as p=0.01.
Supporting Information
Table S1 Primers used for synthesis of double-stranded RNAs
(prefix T7, T7 portion underlined) and for knockdown verification
of target genes (suffix V). Final suffix indicates forward, F, or
reverse, R, sense of primers. Where no V primers are listed (Rel1,
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sequences were also used for verification.
Found at: doi:10.1371/journal.ppat.1000576.s001 (0.04 MB
DOC)
Table S2 Infection prevalence, measured as the fraction of
mosquitoes with at least one midgut oocyst, analyzed using Chi
Square. Oocyst intensity is analyzed only in mosquitoes with
$1midgut oocyst and is analyzed using non-parametric Wilcoxon
Mann Whitney (WMW) tests. Analyses are presented by the figure
number in which the data appears. Values lower than the
significance threshold of p=0.01 are shown in bold. 1: p values
from pooling of replicate experiments for statistical analysis where
there were not significant differences between replicates within
treatments. 2: p values from independent analyses of replicate
experiments and combination of independent p values using the
meta-analysis method of Fisher (see Methods). This approach was
used when there were significant differences within treatment
across replicates.
Found at: doi:10.1371/journal.ppat.1000576.s002 (0.05 MB
DOC)
Table S3 Descriptive results of infections used in corresponding
figures as indicated. Data are shown from pooled replicate
infections. Median and range shown are for mosquitoes with at
least one oocyst. Proportions of infected mosquitoes (infection
prevalence) are shown in the figures.
Found at: doi:10.1371/journal.ppat.1000576.s003 (0.03 MB
DOC)
Figure S1 Constitutive activation of Rel1 by silencing of Cactus
does not influence P. falciparum development. A) dsCactus treatment
efficiently silences cactus gene expression. B) The Cactus-depleted
state, previously shown to constitutively activate Rel1 (see Results)
does not affect the efficiency of P. falciparum development in A.
gambiae.
Found at: doi:10.1371/journal.ppat.1000576.s004 (3.46 MB TIF)
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